UK Healthcare Stocks
34 UK-listed Healthcare companies with a combined market capitalisation of £324.98B. The largest is AstraZeneca PLC (AZN) — 14 AIM, 7 FTSE AIM 100, 6 FTSE 250, 5 FTSE 100, 2 FTSE SmallCap.
All companiesBasic MaterialsCommunication ServicesConsumer CyclicalConsumer DefensiveEnergyFinancial ServicesIndustrialsReal EstateTechnologyUtilities
| Company | Ticker | Index | Market cap |
|---|---|---|---|
| AstraZeneca PLC | AZN | FTSE 100 | £195.54B |
| GSK plc | GSK | FTSE 100 | £74.06B |
| Haleon plc | HLN | FTSE 100 | £28.87B |
| Smith & Nephew plc | SN | FTSE 100 | £8.49B |
| Convatec Group PLC | CTEC | FTSE 100 | £4.03B |
| Hikma Pharmaceuticals PLC | HIK | FTSE 250 | £3.31B |
| Oxford Nanopore Technologies plc | ONT | FTSE 250 | £1.78B |
| Genus plc | GNS | FTSE 250 | £1.44B |
| Spire Healthcare Group plc | SPI | FTSE 250 | £983.47M |
| Uniphar plc | UPR | FTSE AIM 100 | £906.31M |
| CVS Group plc | CVSG | FTSE 250 | £868.42M |
| Oxford Biomedica plc | OXB | FTSE 250 | £626.06M |
| Advanced Medical Solutions Group plc | AMS | FTSE AIM 100 | £615.02M |
| Craneware plc | CRW | FTSE AIM 100 | £354.70M |
| International Biotechnology Ord | IBT | FTSE SmallCap | £352.93M |
| Avacta Group Plc | AVCT | FTSE AIM 100 | £341.10M |
| Allergy Therapeutics plc | AGY | AIM | £329.29M |
| NIOX Group Plc | NIOX | FTSE AIM 100 | £276.30M |
| PureTech Health plc | PRTC | FTSE SmallCap | £272.14M |
| Optima Health plc | OPT | FTSE AIM 100 | £267.59M |
| Tristel plc | TSTL | FTSE AIM 100 | £196.62M |
| Diaceutics PLC | DXRX | AIM | £158.54M |
| Scancell Holdings plc | SCLP | AIM | £127.53M |
| EKF Diagnostics Holdings plc | EKF | AIM | £111.19M |
| INSPECS Group plc | SPEC | AIM | £100.44M |
| 4basebio PLC | 4BB | AIM | £89.04M |
| Bioventix PLC | BVXP | AIM | £88.35M |
| Kooth plc | KOO | AIM | £66.65M |
| Shield Therapeutics plc | STX | AIM | £63.91M |
| ECO Animal Health Group plc | EAH | AIM | £63.55M |
| MedPal AI PLC | MPAL | AIM | £62.38M |
| Poolbeg Pharma PLC | POLB | AIM | £54.20M |
| Creo Medical Group PLC | CREO | AIM | £44.40M |
| hVIVO plc | HVO | AIM | £43.26M |